The Utility of Pre-Treatment Inflammation Markers as Associative Factors to the Adverse Outcomes of Vulvar Cancer: A Study on Staging, Nodal Involvement, and Metastasis Models.
Hariyono WinartoMuhammad HabiburrahmanTricia Dewi AnggraeniKartiwa Hadi NuryantoRenny Anggia JuliantiGatot PurwotoAndrijono AndrijonoPublished in: Journal of clinical medicine (2022)
Inflammatory markers are crucial for identifying the deleterious outcomes of VC. Accordingly, yielded models require external validation.